We are live on
!
Find out more
NCM
Niemann Capital Management Portfolio holdings
AUM
$788K
1-Year Est. Return
23.27%
This Fund
S&P 500
This Quarter
Est. Return
+8.3%
1 Year Est. Return
+23.27%
3 Year Est. Return
+102.79%
5 Year Est. Return
+328.66%
10 Year Est. Return
–
AUM
$172M
AUM Growth
+$18.5M
(+12%)
Cap. Flow
+$10.9M
Cap. Flow
% of AUM
6.3%
Top 10 Holdings %
Top 10 Hldgs %
98.29%
Holding
25
New
8
Increased
5
Reduced
2
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Health Care Equipment ETF
XHE
|
+$25.1M |
| 2 |
XLVS
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
|
+$23.8M |
| 3 |
Invesco S&P MidCap Momentum ETF
XMMO
|
+$20M |
| 4 |
Invesco S&P SmallCap Consumer Discretionary ETF
PSCD
|
+$16.7M |
| 5 |
Amplify Online Retail ETF
IBUY
|
+$6.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Aerospace & Defense ETF
ITA
|
+$27.1M |
| 2 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$22.7M |
| 3 |
Invesco S&P 500 Equal Weight Technology ETF
RSPT
|
+$11M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$7.56M |
| 5 |
GENZ
VanEck Digital Native Economy ETF
GENZ
|
+$7.37M |
Sector Composition
| Rank | Sector | Weight |
|---|
Similar funds
RC
GBA
AIDCT
VAIA
SAM
FPC
GFWEX
HAM
Niemann Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Niemann Capital Management held 25 positions worth $172M, up 12% from $154M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Niemann Capital Management deployed $10.9M of net new capital in Q2 2018, opening 8 new positions and adding to 5 existing holdings. Its largest new stake was State Street SPDR S&P Health Care Equipment ETF: 335,279 shares worth $26.2M.
On the sell side, the largest reduction was Virtus Biotech Clinical Trials ETF, an estimated $36.4K trimmed.
- Niemann Capital Management's largest Q2 2018 buy was State Street SPDR S&P Health Care Equipment ETF: 335,279 shares worth $26.2M.
- Niemann Capital Management added most to POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO in Q2 2018, an estimated $23.8M increase.
- Niemann Capital Management's biggest Q2 2018 reduction was Virtus Biotech Clinical Trials ETF, cutting an estimated $36.4K.
- Niemann Capital Management fully exited iShares US Aerospace & Defense ETF in Q2 2018, selling an estimated $27.1M.
- Niemann Capital Management's ten largest holdings make up 98% of its $172M portfolio in Q2 2018.
- Niemann Capital Management opened 8 new positions and closed 10 in Q2 2018.
- Niemann Capital Management's portfolio value rose 12% quarter-over-quarter to $172M.
Based on Niemann Capital Management's 13F filing for Q2 2018, filed 7 Aug 2018.